首页> 中文期刊>中国骨与关节杂志 >全膝关节置换术后应用抗凝药物预防深静脉血栓的临床研究进展

全膝关节置换术后应用抗凝药物预防深静脉血栓的临床研究进展

     

摘要

Anticoagulant drugs can prevent deep vein thrombosis and related complications after total knee arthroplasty. Traditional anticoagulant drugs (unfractionated heparin, low molecular weight heparin, warfarin, etc.) take preventive effects. At present, some new oral anticoagulants (rivaroxaban, apixababan) have been widely used in clinical practice to provide patients with a safer, more convenient and effective option for the prevention of postoperative venous thrombosis. This review focuses on the advantages and disadvantages of traditional anticoagulants such as low molecular weight heparin, vitamin K antagonists, and novel oral anticoagulants rivaroxaban, apixaban. Clinical comparison of traditional anticoagulant drugs with novel oral anticoagulants is taken to provide a reference.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号